Precigen, Inc. Common Stock (PGEN) Stock Price

PGENStock
$7.28+71.53%52W
Market Cap$2.61B
P/E
PEG Ratio
Div yield
Beta0.99

PGEN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)35.68%
Price vs S&P 500 (4W)26.60%
VGM Score57.21

PGEN Earnings Surprise History

Q2 25-0.08est. -0.08
Q3 25-1.06est. -0.10
Q4 25-0.01est. -0.08
Q1 26-0.02est. -0.04
Q2 260.05est. -0.01

PGEN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.00
4.00
4.00
4.00

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PGENPrecigen, Inc. Common Stock
DBA$7.28
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Precigen, Inc. Common Stock

Precigen Inc develops synthetic biology solutions and engineered gene programs for diverse applications across multiple industries. The company commercializes its technologies through exclusive strategic partnerships, generating revenue from technology access fees, royalties, and milestones. Operations are organized into two reportable segments: Biopharmaceuticals and Exemplar.